Susanne Fleig's Avatar

Susanne Fleig

@sfleig.bsky.social

Nephrologist / Clinical Scientist at RWTH Aachen University Hospital. Vascular biology, tertiary lymphoid structures; outpatient clinic for CKD and hypertension; ultrasound instructor DEGUM2, renal nutrition

273 Followers  |  296 Following  |  22 Posts  |  Joined: 15.01.2025  |  2.1603

Latest posts by sfleig.bsky.social on Bluesky


I love the idea! However, there is a bug for European users: some of us have a different separator (ph 7,3 instead of 7.3) - my keyboard does not allow to enter a point as separator. Could you allow both in the app (7.3 and 7,3)?

09.02.2026 21:40 — 👍 1    🔁 0    💬 1    📌 0
Preview
A universal flu vaccine has proved challenging — could it finally be possible? Scientists are deploying an array of technologies that are making a vaccine against all varieties of influenza seem more achievable.

Nature outlines how scientists are deploying an array of technologies that are making a vaccine against all varieties of influenza seem more achievable. #immunosky #medsky 🧪

14.01.2026 17:23 — 👍 18    🔁 4    💬 1    📌 0
Postgraduate Associate – Koh Lab, Yale Stem Cell Center, Department of Comparative Medicine, Yale School of Medicine

postdocs.yale.edu/posts/2025-1...

The Koh Lab is hiring!! Please reach out to join our newly established lab as a postgraduate associate! Come help us write the first exciting chapter of our (hopefully epic) saga! #CraniofacialBM #HSCniche #Vascularbiology #Immunology #YaleStemCellCenter #YaleCMED

05.12.2025 19:01 — 👍 9    🔁 5    💬 0    📌 0
Grafik mit blauem Rahmen und hellblauem Hintergrund. Text: „Schon gegen Grippe geimpft? Der Beginn der Grippewelle deutet sich an“. Rechts unten eine Illustration mit zwei Personen: eine Person im gelben Oberteil hält sich den Hals, daneben/hinter ihr eine Person im grünen Oberteil niest in ein Taschentuch. Unten steht: „Robert Koch-Institut“.

Grafik mit blauem Rahmen und hellblauem Hintergrund. Text: „Schon gegen Grippe geimpft? Der Beginn der Grippewelle deutet sich an“. Rechts unten eine Illustration mit zwei Personen: eine Person im gelben Oberteil hält sich den Hals, daneben/hinter ihr eine Person im grünen Oberteil niest in ein Taschentuch. Unten steht: „Robert Koch-Institut“.

Grafik mit blauem Hintergrund. Überschrift: „Aktuelle Situation“. Text: „Die Aktivität akuter Atemwegserkrankungen ist auf Bevölkerungsebene und im ambulanten Bereich gestiegen und liegt auf einem moderaten bzw. hohen, aber nicht unüblichen Niveau. Die Zahl schwer verlaufender Atemwegserkrankungen ist weiter niedrig. Das ARE-Geschehen wird seit mehreren Monaten hauptsächlich durch die Zirkulation von Rhinoviren und SARS-CoV-2 bestimmt.“ Darunter ein Kasten mit Glühbirnen-Symbol und Text: „Die Influenza-Positivenrate ist in den letzten zwei Wochen deutlich angestiegen, der Beginn der Grippewelle deutet sich an. Es zirkulierten bisher hauptsächlich Influenza A(H3N2)- und A(H1N1)pdm09-Viren.“ Unten steht: „Robert Koch-Institut“.

Grafik mit blauem Hintergrund. Überschrift: „Aktuelle Situation“. Text: „Die Aktivität akuter Atemwegserkrankungen ist auf Bevölkerungsebene und im ambulanten Bereich gestiegen und liegt auf einem moderaten bzw. hohen, aber nicht unüblichen Niveau. Die Zahl schwer verlaufender Atemwegserkrankungen ist weiter niedrig. Das ARE-Geschehen wird seit mehreren Monaten hauptsächlich durch die Zirkulation von Rhinoviren und SARS-CoV-2 bestimmt.“ Darunter ein Kasten mit Glühbirnen-Symbol und Text: „Die Influenza-Positivenrate ist in den letzten zwei Wochen deutlich angestiegen, der Beginn der Grippewelle deutet sich an. Es zirkulierten bisher hauptsächlich Influenza A(H3N2)- und A(H1N1)pdm09-Viren.“ Unten steht: „Robert Koch-Institut“.

Grafik mit blauem Hintergrund und einem runden Symbol (Globus mit Mauszeiger). Text: „Informationen zu Akuten Atemwegserkrankungen und zur aktuellen Situation findet ihr unter: rki.de/are“. Darunter ein weißer Kasten mit Überschrift „Etwas gelernt?“ und den Optionen „Liken“, „Reposten“, „Teilen“, „Speichern“. Unten steht: „Robert Koch-Institut“.

Grafik mit blauem Hintergrund und einem runden Symbol (Globus mit Mauszeiger). Text: „Informationen zu Akuten Atemwegserkrankungen und zur aktuellen Situation findet ihr unter: rki.de/are“. Darunter ein weißer Kasten mit Überschrift „Etwas gelernt?“ und den Optionen „Liken“, „Reposten“, „Teilen“, „Speichern“. Unten steht: „Robert Koch-Institut“.

Der Beginn der Grippewelle deutet sich an.
Die aktuellen Daten im ARE-Wochenbericht zeigen, dass die ans RKI übermittelten Influenza-Fälle in den letzten zwei Wochen deutlich angestiegen sind.
Personen die zur Risikogruppe gehören und bisher nicht geimpft sind, sollten dies nachholen.
👉 www.rki/are

04.12.2025 09:03 — 👍 112    🔁 44    💬 9    📌 6
Preview
A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis Folate metabolism is intricately linked to purine de novo synthesis through the incorporation of folate-derived one-carbon units into the purine scaffold. By investigating chemical and genetic depende...

New in @science.org 🧬

What if an enzyme you thought you knew turned out to control metabolism in a completely new way?

We found that NUDT5 acts as a molecular handbrake on purine synthesis, reshaping how cells make DNA building blocks and respond to cancer drugs.

www.science.org/doi/10.1126/...

06.11.2025 19:30 — 👍 21    🔁 11    💬 2    📌 3
Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin | Journal of Experimental Medicine | Rockefeller University Press This study reveals how the structure and cellular morphology of human dermal afferent lymphatic vessels differ from the current, primarily mouse tissue–bas

❣️New in @JExpMed

Proud to have contributed to the work of Cornelia Halin’s lab @ETH_en !

Single-cell & 3D imaging reveal unexpected diversity of human afferent lymphatic vessels including unique CD24⁺ valve LECs and key differences from mouse skin.

rupress.org/jem/article/...

06.11.2025 12:21 — 👍 5    🔁 3    💬 0    📌 0

Good coffee, good science!

01.10.2025 09:23 — 👍 1    🔁 1    💬 0    📌 0

would the original star wars movies count?
„a long time ago in a galaxy far, far away….“ - not spoken though, written intro.

21.09.2025 20:31 — 👍 1    🔁 0    💬 0    📌 0
Preview
Is it time to retire confirmatory testing for primary aldosteronism? Abstract. Primary aldosteronism(PA) is the most common endocrine hypertension. For decades, PA diagnosis has required proving non-suppressibility of aldost

academic.oup.com/ajh/advance-...

07.09.2025 01:16 — 👍 5    🔁 2    💬 0    📌 0
Preview
Long-Term Mortality After Renal Artery Stenting in Patients With Severe Atherosclerotic Renal Artery Stenosis and High-Risk Clinical Manifestations AbstractBACKGROUND. Atherosclerotic renal artery stenosis is a risk factor for cardiovascular death. Observational studies support the benefit of renal rev

#WeekendReads

Long term mortality after Renal Artery Stenting

🔗 academic.oup.com/ajh/article/... 🔓

#EditorsChoice #Free

07.09.2025 12:30 — 👍 3    🔁 2    💬 0    📌 0
Post image

Kidney dysfunction was diagnosed at 5-months postpartum in 12% of patients who had gestational diabetes mellitus. Read more in #ASNCJASN kidney.pub/CJASN0802

07.09.2025 14:00 — 👍 4    🔁 1    💬 0    📌 0
Post image

New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849

06.09.2025 14:00 — 👍 9    🔁 6    💬 0    📌 0

If you are a nephrology or kidney disease or renal professional or interested in the field - make sure you have liked/followed/pinned the nephrology feed

bsky.app/profile/did:...

Thanks again to @richardferro.xyz for creating & updating this! It’s a one-stop shop for nephrology needs

#NephSky

05.09.2025 16:18 — 👍 24    🔁 11    💬 2    📌 1

Should you, too, feel like your brain is shrinking during the winter: here is why! 👇
(now, how closely related are we really to shrews!)

05.09.2025 11:21 — 👍 2    🔁 0    💬 0    📌 0
Post image Post image

Now open access in @ndt-era.bsky.social

Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: Biological challenges and clinical implications

🧐 Clinical implementation of anti-slit diaphragm antibody testing = precision dx and tx in podocytopathies

▶️ academic.oup.com/ndt/article/...

16.08.2025 06:59 — 👍 18    🔁 8    💬 0    📌 0
Post image

Spread the word: The European Center for Angioscience @uniheidelberg.bsky.social continues to grow: We have openings for 2 additional Junior Group Leader positions. Get in touch with us if you are ready to start your own lab. See also corresponding ad in @nature.com: www.nature.com/naturecareer...

14.07.2025 10:08 — 👍 17    🔁 18    💬 0    📌 3
Preview
Wihuri Research Institute Symposium 2025 - Wihuri Research Institute Since 2013, the Wihuri Research Institute (WRI) has been organizing the annual WRI Symposium, providing a platform for researchers and students to share knowledge and insights in cardiovascular resear...

Exciting days ahead at the Wihuri Research Institute @wrihelsinki.bsky.social as we host #WRISymposium and #EVBOSummerSchool next week in Helsinki.

Looking forward to inspiring talks and scientific exchange with the #VascularBiology community!

wri.fi/research-act...
evbo.org/index.php/ev...

08.06.2025 12:28 — 👍 8    🔁 4    💬 0    📌 0
Post image

We also congratulate Dr. Laetitia Préau from Karlsruhe Institute of Technology (KIT) and Dr.Tore Bleckwehl from Uniklinik RWTH Aachen for their outstanding presentations

@cpi-exstra.bsky.social @sfb1531.bsky.social @sfleig.bsky.social

#PCVB2025

28.05.2025 08:01 — 👍 3    🔁 3    💬 0    📌 0

🔬 Congrats to the 2025 #GfMVB Award Winners! 🏆

Proudly #sponsored by ibidi at “Perspectives in Cardiovascular Biology” Conference🫀

🏅Emerging Scientist: Dr. Haaglim Cho from
@mpi-hlr.bsky.social

🏅Young Investigator: Dr. Julian Wagner from Universitätsmedizin Frankfurt

🔗https://zurl.co/IAJmC

28.05.2025 08:01 — 👍 3    🔁 3    💬 1    📌 0
Post image

Resolution of steatohepatitis without worsening of fibrosis occurred in 62.9% in the semaglutide group & in 34.3% in the placebo group.
Reduction in liver fibrosis without worsening of steatohepatitis was reported in 36.8% in the semaglutide group & in 22.4% in the placebo group
tinyurl.com/338u24b2

03.05.2025 05:38 — 👍 4    🔁 2    💬 0    📌 0
Vasopressin-Mangel (ehemalig Diabetes Insipidus) - Prof. Dr. Mirjam Christ-Crain (Basel, Schweiz)
YouTube video by MARKUS at HOMe Vasopressin-Mangel (ehemalig Diabetes Insipidus) - Prof. Dr. Mirjam Christ-Crain (Basel, Schweiz)

Our Friday-Webinar with @christ-crain.bsky.social !

We talk about diagnosis and treatment of arginine vasopressin deficiency with our expert in german language!

youtu.be/jSl5K0aRTvs?...

02.05.2025 16:16 — 👍 6    🔁 3    💬 0    📌 0
Post image

B cell-derived exosomal miR-483-5p and its potential role in promoting kidney function loss in IgA nephropathy

doi.org/10.1016/j.kint.2025.03.019

#OpenAccess #MedSky #NephSky #SkyNeph #IgAN #IgAnephropathy

28.04.2025 16:29 — 👍 2    🔁 2    💬 0    📌 0
Preview
Academic Europe - Full Professorship for Nephrology

Job - Alert 🚑

🩺 Full Professorship for Nephrology

Deadline: 2025-05-03

Location: Switzerland, Bern

www.academiceurope.com/job/?id=7332

#hiring #Nephrology #medicine #biomedicine #Leadership #professor #director

04.04.2025 08:19 — 👍 0    🔁 2    💬 0    📌 0
Post image

Congrats to Maria Dekrolia, Nivethitha Manickam, Leah Vanicek, and Sofia de la Puente Secades for receiving the Aletta Jacobs Award at the PCVB Meeting 2025 in Frankfurt! A well-deserved recognition of their outstanding contributions to science. #PCVB2025 #AlettaJacobsAward

05.04.2025 10:08 — 👍 7    🔁 3    💬 0    📌 0
Post image

Tore Bleckwehl from Aachen presenting as a finalist in the GfMVB Emerging Scientist Award session at #PCVB2025 in Frankfurt!

05.04.2025 11:11 — 👍 2    🔁 0    💬 0    📌 0
Post image

Excited to share the most recent work from our lab and results from two exciting cooperations:

In this week's issue of @bloodjournal.bsky.social (ashpublications.org/blood/issue), Afra Anjum presents her cover story on how aging platelets gain inflammatory functions in the circulation. 1/4

05.04.2025 05:51 — 👍 9    🔁 4    💬 1    📌 0
A graph showing the least-squares mean percent change in the lipoprotein(a) concentration from baseline through 540 days in the efficacy analysis set, which included data from participants who received at least one dose of lepodisiran or placebo, with the exclusion of data collected from participants after discontinuation of lepodisiran or placebo or initiation of medications known to affect lipoprotein(a).

A graph showing the least-squares mean percent change in the lipoprotein(a) concentration from baseline through 540 days in the efficacy analysis set, which included data from participants who received at least one dose of lepodisiran or placebo, with the exclusion of data collected from participants after discontinuation of lepodisiran or placebo or initiation of medications known to affect lipoprotein(a).

Presented at #ACC25:

Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels. Full ALPACA trial results: nej.md/4kWjJyn

#MedSky @accintouch.bsky.social

30.03.2025 18:35 — 👍 11    🔁 8    💬 0    📌 1
Post image

During inflammation, CCL21 is down-regulated in the lymph node. Enzymes for production of oxysterols are induced and recruitment of naive/central memory cells relies more in oxysterols interacting with GPR183 (+ CCL19). in 🐭

Chen et al @cellpress.bsky.social 2025
pubmed.ncbi.nlm.nih.gov/39708807/

30.03.2025 18:34 — 👍 5    🔁 3    💬 0    📌 0

Finally!

(Psst it was never the fluid, it was always the sodium)

30.03.2025 20:56 — 👍 30    🔁 10    💬 4    📌 0
Post image

Cardiovascular, Kidney & Mortality Outcomes With Long-Acting Injectable & Oral GLP1-RA in T2 Diabetes

An updated meta-analysis of >70,000 patients after the SOUL trial

⬇️ 14% MACE
⬇️ 14% heart failure
⬇️ 17% CKD progression
⬇️ 12% all-cause mortality

diabetesjournals.org/care/article...

29.03.2025 22:00 — 👍 11    🔁 5    💬 0    📌 0

@sfleig is following 20 prominent accounts